|
DK35124C
(da)
|
1924-03-19 |
1925-10-12 |
Niels Christian Carl S Nielsen |
Anordning ved Ægisolatorer og lignende.
|
|
DK72517C
(da)
|
1948-04-08 |
1951-05-15 |
Hans Dr Ing Wolf |
Kobling til paralleldrift af vekselstrømsmotorer.
|
|
DK101373C
(da)
|
1962-03-16 |
1965-03-29 |
Hoechst Ag |
Fremgangsmåde til fremstilling af vandopløselige monoazofarvestoffer.
|
|
EP0008864A1
(en)
|
1978-08-15 |
1980-03-19 |
FISONS plc |
Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
|
|
ZA794209B
(en)
|
1978-08-15 |
1980-07-30 |
Fisons Ltd |
Pharmaceutically active heterocyclic compounds
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
JPS62126178A
(ja)
*
|
1985-11-26 |
1987-06-08 |
Mitsubishi Petrochem Co Ltd |
新規トリアジン誘導体及びこれを含む除草剤
|
|
US5236952A
(en)
|
1986-03-11 |
1993-08-17 |
Hoffmann-La Roche Inc. |
Catechol derivatives
|
|
JP2594486B2
(ja)
|
1991-01-15 |
1997-03-26 |
アルコン ラボラトリーズ インコーポレイテッド |
局所的眼薬組成物
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
AU5433594A
(en)
|
1992-11-19 |
1994-06-08 |
Dainippon Pharmaceutical Co. Ltd. |
3,4-dihydro-1-(2-hydroxyphenyl)-2(1h)-quinoxalinone derivative and related compound
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
EP1004307B1
(en)
|
1998-01-30 |
2002-09-04 |
R-Tech Ueno, Ltd. |
Ophthalmic composition
|
|
EP0945447A1
(en)
|
1998-03-27 |
1999-09-29 |
Janssen Pharmaceutica N.V. |
Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
|
|
GB9806739D0
(en)
|
1998-03-28 |
1998-05-27 |
Univ Newcastle Ventures Ltd |
Cyclin dependent kinase inhibitors
|
|
KR20010042298A
(ko)
|
1998-03-31 |
2001-05-25 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
인자 Ｘａ 및 트롬빈과 같은 세린 프로테아제억제제로서의 퀴녹살리논
|
|
EP1246823A1
(en)
*
|
1999-12-28 |
2002-10-09 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
|
US7163943B2
(en)
*
|
2001-09-21 |
2007-01-16 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
|
WO2003024926A2
(en)
*
|
2001-09-21 |
2003-03-27 |
Reddy Us Therapeutics, Inc. |
Methods and compositions of novel triazine compounds
|
|
AU2003272740A1
(en)
*
|
2002-10-01 |
2004-04-23 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors
|
|
WO2005009980A1
(en)
*
|
2003-07-22 |
2005-02-03 |
Neurogen Corporation |
Substituted pyridin-2-ylamine analogues
|
|
MXPA06008606A
(es)
|
2004-01-30 |
2007-04-13 |
Vertex Pharma |
Moduladores de transportadores con casete de union a atp.
|
|
US7335770B2
(en)
*
|
2004-03-24 |
2008-02-26 |
Reddy U5 Therapeutics, Inc. |
Triazine compounds and their analogs, compositions, and methods
|
|
DE102004023332A1
(de)
|
2004-05-12 |
2006-01-19 |
Bayer Cropscience Gmbh |
Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung
|
|
CA2600869A1
(en)
*
|
2005-03-18 |
2006-09-28 |
The Regents Of The University Of California |
Compounds having activity in correcting mutant-cftr processing and uses thereof
|
|
WO2007095812A1
(en)
|
2006-02-27 |
2007-08-30 |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof
|
|
CA2657093A1
(en)
*
|
2006-07-07 |
2008-01-10 |
Steven P. Govek |
Bicyclic heteroaryl inhibitors of pde4
|
|
MX2009012610A
(es)
|
2007-05-22 |
2009-12-11 |
Astellas Pharma Inc |
Compuesto de tetrahidroisoquinolina 1-sustituido.
|
|
US20090105240A1
(en)
|
2007-10-17 |
2009-04-23 |
Tomas Mustelin |
Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same
|
|
WO2009091388A2
(en)
*
|
2007-12-21 |
2009-07-23 |
Progenics Pharmaceuticals, Inc. |
Triazines and related compounds having antiviral activity, compositions and methods thereof
|
|
EP2247580B1
(en)
|
2008-03-05 |
2015-07-08 |
Merck Patent GmbH |
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
|
|
US8314239B2
(en)
|
2008-10-23 |
2012-11-20 |
Vertex Pharmaceutical Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
WO2010073011A2
(en)
|
2008-12-23 |
2010-07-01 |
Betagenon Ab |
Compounds useful as medicaments
|
|
SI2408750T1
(sl)
*
|
2009-03-20 |
2015-11-30 |
Vertex Pharmaceuticals Incorporated |
Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
|
|
FR2958645B1
(fr)
|
2010-04-09 |
2012-08-31 |
Commissariat Energie Atomique |
Hemi-anticorps a auto-assemblage
|
|
ES2608474T3
(es)
*
|
2010-04-22 |
2017-04-11 |
Vertex Pharmaceuticals Incorporated |
Proceso de producción de compuestos indol cycloalkylcarboxamido
|
|
WO2012092471A2
(en)
|
2010-12-29 |
2012-07-05 |
Development Center For Biotechnology |
Novel tubulin inhibitors and methods of using the same
|
|
US9303035B2
(en)
|
2012-12-19 |
2016-04-05 |
Novartis Ag |
Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel
|
|
HUE040366T2
(hu)
|
2013-08-08 |
2019-03-28 |
Galapagos Nv |
CFTR modulátor tieno[2,3-c]piránok
|
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
|
CA2996854C
(en)
|
2015-09-11 |
2022-11-29 |
Ion-Tof Technologies Gmbh |
Secondary ion mass spectrometer and secondary ion mass spectrometric method
|
|
MX383072B
(es)
*
|
2015-12-24 |
2025-03-13 |
Univ California |
Reguladores del cftr y métodos para su uso
|
|
JP6894902B2
(ja)
|
2015-12-24 |
2021-06-30 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
Ｃｆｔｒ制御因子及びこの使用方法
|
|
CN109302846B
(zh)
|
2015-12-24 |
2021-05-11 |
莱斯彼维特有限公司 |
吲哚啉酮化合物及其在纤维化疾病治疗中的用途
|
|
ES2913051T3
(es)
|
2015-12-24 |
2022-05-31 |
Univ California |
Reguladores de CFTR y métodos de uso de los mismos
|
|
JP2020531511A
(ja)
|
2017-08-24 |
2020-11-05 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
眼球用医薬組成物
|
|
JP7256631B2
(ja)
|
2018-11-01 |
2023-04-12 |
株式会社豊田中央研究所 |
距離測定装置
|